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The contributions to this issue of Springer Seminars in Immunopathology provide 
important updates on key functions of antibodies in normal defenses, autoimmunity, 
and immunoregulation/therapeutic immunomodulation, as well as on the regulation 
of the B lymphocyte responses that produce them, and the mechanisms underlying 
their diversity. 
Antibodies serve as B cell receptors (BCR) for antigens in immune responses. 
Early forms of the BCR, expressed in pro-B and pre-B cells, regulate B cell matura- 
tion. Evidence indicating that ligand-independent signaling occurs in immature B 
cell stages, and also for the maintenance of viability of mature B cells, is reviewed 
by Ezequiel Fuentes-Panan~i and John Monroe. 
The conflict between the generation of antibody diversity and the maintenance of
self-tolerance was recognized by the early immunologists. Current knowledge of 
mechanisms of tolerance that operate at different stages of lymphocyte maturation i  
central and peripheral immune organs, and particularly the problem of tolerance to 
the central nervous ystem, is reviewed by Antonio Iglesias. 
Somatic hypermutation f variable-region genes (V, D, J) is a B-cell-specific fea- 
ture of adaptive immunity. Which human B cell subsets express hypermutated anti- 
bodies, the mutation patterns and the mechanisms - the emergent roles of multiple 
error-prone DNA polymerases - involved in this aspect of antigen receptor/antibody 
repertoire diversity are reviewed by Nancy Longo and Peter Lipsky. 
Repertoires of antibodies reacting with polysaccharide-encapsulated bacteria have 
been extensively investigated (V-genes, mutations). These organisms are medically 
important; heir key antigens are of the T-independent type 2 (T12) and young chil- 
dren are particularly susceptible. Conjugate vaccines for the stimulation of T-depen- 
dent responses to T12 are among the most remarkable achievements of immunology, 
as reviewed by Elisabeth Adderson. 
Different subsets of newly generated B cells home to microenvironments optimal 
for either T-dependent orT-independent responses. Functionally experienced, V(D)J 
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mutated memory B cells produced in T-dependent responses then also become avail- 
able for T-independent responses. Many memory B ceils conserve their class-switch 
capacity, others are isotype-stabilized, as reviewed by Rudolf Zubler. 
Antibodies have the capacity to regulate their own production, and antibody feed- 
back-suppression f B cell responses i powerful. This function, as well as antibody- 
mediated enhancement, involves a variety of mechanisms that are isotype-dependent 
and/or epitope-specific. All immunoglobulin isotypes have immunoregulatory ef- 
fects, as reviewed by Birgitta Heyman. 
Effector functions of antibodies are also largely isotype-specific, but the role of 
different Fc receptors or complement in the immunopathogenicity of antibodies in 
vivo is often not predictable from studies in vitro. The combined effects of isotype 
and valency/affinity for the antigen can be analyzed quantitatively in appropriate in
vivo models, as reviewed by Shozo Izui et al. 
In accordance with their diverse biological functions, mixtures of human antibod- 
ies have strong immunomodulatory effects in certain autoimmune diseases. Clinical 
experience with high-dose i.v. immunoglobulins in various diseases, deriving from 
controlled or still preliminary studies, is critically reviewed by Lubica Rauova, Jozef 
Rovensky and Yehuda Schoenfeld. 
